Keywords: geltex, wins, approval, lipid-lowering, drug, welchol, pharmaceuticals
GelTex wins US approval for lipid-lowering drug Welchol
Article | 01 June 2000
GelTex Pharmaceuticals and partner Sankyo Parke-Davis have gained USFood and Drug Administration backing for the former's novel lipid-lowering agent Welchol ( ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Italy's pharma market slump set to continue, warns GlobalData
